Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$414,176
-$223,240 QoQ
Shares Held
17,200
-24.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,886
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 58%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NICHOLS & PRATT ADVISERS LLP /MA holds $207,768,859 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
460,889 | $117,051,979 | |
| 2 | MRK |
Merck & Co., Inc.
|
442,799 | $56,899,671 | |
| 3 | NVO |
Novo Nordisk A S
|
477,675 | $22,899,738 | |
| 4 | ABBV |
AbbVie Inc.
|
24,617 | $6,194,621 | |
| 5 | NVS |
Novartis AG
|
17,297 | $2,710,784 | |
| 6 | AMGN |
Amgen Inc
|
2,897 | $1,049,060 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,525 | $548,830 | |
| 8 | PFE |
Pfizer Inc
This page
|
17,200 | $414,176 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $414,176 | 17,200 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $637,416 | 22,700 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $565,230 | 22,700 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $591,136 | 23,200 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $824,135 | 33,999 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,215,939 | 47,985 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,342,550 | 50,605 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $1,508,728 | 52,133 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,458,680 | 52,133 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,487,843 | 53,616 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,549,390 | 53,817 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,826,737 | 55,072 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,145,485 | 58,492 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,396,673 | 58,742 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,021,673 | 58,971 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,414,763 | 55,182 | Shares | Other | 2022-11-01 | |
| 2022-06-30 | $2,836,829 | 54,107 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,801,118 | 54,107 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,195,018 | 54,107 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,531,438 | 58,857 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,306,797 | 58,907 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,134,200 | 58,907 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,141,052 | 58,165 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,134,652 | 58,165 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,971,484 | 60,290 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,187,594 | 67,022 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||